A quick wrap-up of the latest exhale of mostly good news for the medical marijuana industry, Medical Marijuana Inc (OTCMKTS: MJNA) and indirect player Growlife Inc (OTCBB: PHOT).

I have been so focused on transparency and accounting issues that I have missed what may be an even bigger part of the story: Medical Marijuana Inc. (MJNA.PK) gets no benefit from sales of Dixie Elixirs and other Dixie products in Colorado. I first ...

Medical Marijuana Inc., is in the business of researching, developing, investing and selling products and services within the legal medicinal cannabis and industrial hemp industries.

In what can only be described as a two-minute drill, Medical Marijuana Inc. (MJNA.PK) delivered on its promise to get its Q1 OTC filing with audited Q1 results posted by 5/15, as the company had indicated in its 4/30 press release.

I first learned of Medical Marijuana, Inc. (MJNA.PK) in February, when anonymous, self-proclaimed short "Infitialis" called the company a "fraud heaped on top of folly.

Medical Marijuana Inc (OTCMKTS:MJNA) ended low -6.17% and complete the day at 0.152. The total number of shares changed hands during the day was 11.16 million.

NTRR has made California the staging point for its efforts to build market share in the industry by basing its new medicinal cannabis subsidiary--Cannabis Technologies, Inc.--in Los Angeles. Since voters approved California's medical marijuana program ...

Medical Marijuana Inc (OTCMKTS:MJNA) closed yesterday at $0.162, a -6.02% decrease. Around 5.89 million shares were traded, low from an-average trading volume of 8.48 million shares.

Many traders eagerly anticipated the latest quarterly filing of Medical Marijuana, Inc. (OTCMKTS:MJNA, MJNA message board) and now it is out.

Medical Marijuana Inc (OTCMKTS:MJNA) stock is at $0.172, down -10.21 percent from its previous close of $0.192. The stock opened the session at $0.19 and touched its highest price point at $0.20.